Suchergebnisse - "Skydel, Joshua J"

PubPharm (12)

1

Geographic and Demographic Representation in Industry-Sponsored, US-Based Clinical Trials of Systemic Lupus Erythematosus Therapies

enthalten in: The Journal of rheumatology | 2024

von Skydel, J. | Ramachandran, R. | Suttiratana, S. | +3

2

Characterization of accelerated approval status, trial endpoints and results, and recommendations in guidelines for oncology drug treatments from the National Comprehensive Cancer Network : cross sectional study

enthalten in: BMJ medicine | 2024

von Mooghali, M. | Mitchell, A. | Skydel, J. | +3

3

Agreement of treatment effects from observational studies and randomized controlled trials evaluating hydroxychloroquine, lopinavir-ritonavir, or dexamethasone for covid-19 : meta-epidemiological study

enthalten in: BMJ (Clinical research ed.) | 2022

von Moneer, O. | Daly, G. | Skydel, J. | +4

4

Spending by the Centers for Medicare & Medicaid Services Before and After Confirmation of Benefit for Drugs Granted US Food and Drug Administration Accelerated Approval, 2012 to 2017

enthalten in: JAMA health forum | 2022

von Skydel, J. | Egilman, A. | Wallach, J. | +3

5

U.S. Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009-2018

enthalten in: bioRxiv.org | 2021

von Skydel, J. | Zhang, A. | Dhruva, S. | +2

6

Feasibility of Using Real-world Data to Emulate Postapproval Confirmatory Clinical Trials of Therapeutic Agents Granted US Food and Drug Administration Accelerated Approval

enthalten in: JAMA network open | 2021

von Wallach, J. | Zhang, A. | Skydel, J. | +4

7

US Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009-2018

enthalten in: Clinical trials (London, England) | 2021

von Skydel, J. | Zhang, A. | Dhruva, S. | +2

8

Reporting of Study Participant Demographic Characteristics and Demographic Representation in Premarketing and Postmarketing Studies of Novel Cancer Therapeutics

enthalten in: JAMA network open | 2021

von Varma, T. | Wallach, J. | Miller, J. | +6

CommentIn: JAMA Netw Open. 2021 Apr 1;4(4):e217159. - PMID 33877312

9

Characteristics and Reporting of Number Needed to Treat, Number Needed to Harm, and Absolute Risk Reduction in Controlled Clinical Trials, 2001-2019

enthalten in: JAMA internal medicine | 2021

von Elliott, M. | Skydel, J. | Dhruva, S. | +2

10

Publishing at any cost : a cross-sectional study of the amount that medical researchers spend on open access publishing each year

enthalten in: BMJ open | 2021

von Ellingson, M. | Shi, X. | Skydel, J. | +4